Nivolumab in Esophageal Squamous-Cell Carcinoma
N Engl J Med
.
2022 May 19;386(20):1958-1959.
doi: 10.1056/NEJMc2202880.
Authors
Muhammet Ozer
1
,
Ilyas Sahin
2
Affiliations
1
Capital Health Regional Medical Center, Trenton, NJ.
2
University of Florida Health Cancer Center, Gainesville, FL i.sahin@ufl.edu.
PMID:
35584166
DOI:
10.1056/NEJMc2202880
No abstract available
Publication types
Letter
Comment
MeSH terms
Esophageal Neoplasms* / drug therapy
Esophageal Squamous Cell Carcinoma* / drug therapy
Esophageal Squamous Cell Carcinoma* / pathology
Humans
Nivolumab / therapeutic use
Substances
Nivolumab